Your browser doesn't support javascript.
loading
Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands.
Garman, Bradley; Jiang, Can; Daouti, Sherif; Kumar, Sanah; Mehta, Priyanka; Jacques, Miye K; Menard, Laurence; Manjarrez-Orduno, Nataly; Dolfi, Sonia; Mukherjee, Piali; Rai, Sharmila Chamling; Lako, Ana; Koenitzer, Jennifer D; David, Justin M.
Afiliación
  • Garman B; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Jiang C; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Daouti S; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Kumar S; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Mehta P; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Jacques MK; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Menard L; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Manjarrez-Orduno N; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Dolfi S; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Mukherjee P; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Rai SC; Epigenomics Core Facility, Weill Cornell Medicine, New York City, NY, United States.
  • Lako A; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • Koenitzer JD; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
  • David JM; Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ, United States.
Front Immunol ; 14: 1151748, 2023.
Article en En | MEDLINE | ID: mdl-37795090

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos